A detailed history of Wealthstream Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealthstream Advisors, Inc. holds 3,185 shares of NVO stock, worth $337,482. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,185
Previous 3,065 3.92%
Holding current value
$337,482
Previous $437,000 13.27%
% of portfolio
0.08%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $14,288 - $17,450
120 Added 3.92%
3,185 $379,000
Q2 2024

Jul 29, 2024

BUY
$122.71 - $146.91 $4,662 - $5,582
38 Added 1.26%
3,065 $437,000
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $23,485 - $31,261
230 Added 8.22%
3,027 $388,000
Q4 2023

Feb 12, 2024

SELL
$87.78 - $105.45 $5,530 - $6,643
-63 Reduced 2.2%
2,797 $289,000
Q3 2023

Nov 06, 2023

BUY
$90.94 - $199.54 $260,088 - $570,684
2,860 New
2,860 $260,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wealthstream Advisors, Inc. Portfolio

Follow Wealthstream Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthstream Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealthstream Advisors, Inc. with notifications on news.